BI 2536 Uses, Dosage, Side Effects and more
BI 2536 is under investigation in clinical trial NCT00376623 (Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer).
| Trade Name | BI 2536 |
| Generic | BI 2536 |
| Type | |
| Formula | C28H39N7O3 |
| Weight | Average: 521.666 Monoisotopic: 521.311438144 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
